In Vitro Potency and In Vivo Efficacy of a Novel Bis-Indole Antimicrobial Compound in Reducing Catheter Colonization
暂无分享,去创建一个
[1] B. Akgun,et al. Use of Antibiotic - Impregnated DuraGen® to Reduce the Risk of Infection in Dura Repair: An In Vitro Study , 2011, Central European neurosurgery.
[2] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2002, American journal of infection control.
[3] P. Flynn. Infection Associated with Medical Devices , 2011 .
[4] Sanjay Saint,et al. Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] D. Moir,et al. Comparative In Vitro Activity Profiles of Novel Bis-Indole Antibacterials against Gram-Positive and Gram-Negative Clinical Isolates , 2010, Antimicrobial Agents and Chemotherapy.
[6] E. A. Stevens,et al. Effects of antibiotic-impregnated external ventricular drains on bacterial culture results: an in vitro analysis. , 2010, Journal of neurosurgery.
[7] R. Darouiche,et al. Comparative assessment of antimicrobial activities of antibiotic-treated penile prostheses. , 2009, European urology.
[8] R. Ulrich,et al. Novel Broad-Spectrum Bis-(Imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains , 2009, Antimicrobial Agents and Chemotherapy.
[9] M. Butler. Novel bis-(imidazolinylindole) Antibacterials Active Against a Broad Spectrum of Bacteria , 2008 .
[10] D. Maki,et al. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. , 2007, The Lancet. Infectious diseases.
[11] Y. Mehta,et al. Device-Associated Nosocomial Infections in 55 Intensive Care Units of 8 Developing Countries , 2006, Annals of Internal Medicine.
[12] J. Fine,et al. Meta-Analysis: Methods for Diagnosing Intravascular DeviceRelated Bloodstream Infection , 2005, Annals of Internal Medicine.
[13] D. Kovacevich,et al. Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[14] D. Maki,et al. The role of intravascular devices in sepsis , 2001, Current infectious disease reports.
[15] R. D'Agostino,et al. Prolonged Antimicrobial Activity of a Catheter Containing Chlorhexidine-Silver Sulfadiazine Extends Protection against Catheter Infections In Vivo , 2001, Antimicrobial Agents and Chemotherapy.
[16] R Consunji,et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. , 2001, Archives of surgery.
[17] J. Rello,et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. , 2000, American journal of respiratory and critical care medicine.
[18] L. Mermel,et al. Prevention of intravascular catheter-related infections. , 1994, Annals of internal medicine.
[19] O. Wenker,et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. , 1999, The New England journal of medicine.
[20] G. Bodey,et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. , 1996, The Journal of infectious diseases.
[21] R. Sherertz,et al. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. , 1993, The Journal of infectious diseases.
[22] R. Sherertz,et al. Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice , 1989, Antimicrobial Agents and Chemotherapy.